State Ledger
Company profile

NextCure, Inc. CIK 1661059

Ticker
NXTC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Baltimore, MD 21209
Fiscal year end
2025 (FY)
Market Data
Close
$6.42
Change
-$0.23
Change %
-3.46%
Volume
1,707

NXTC · trading date Oct 13, 2026 · previous close $6.65 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$55.84M
Total assets
$50.18M
Total liabilities
$15.24M
Stockholders' equity
$34.94M
Cash & equivalents
$25.98M
Operating income
-$57.62M
Operating cash flow
-$49.61M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-05. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
30.4%
Equity / assets
69.6%
CapEx / revenue
—
Operating cash flow / net income
0.89×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$55.84M $50.18M $15.24M $34.94M
2024 — -$55.65M $80.86M $15.39M $65.47M
2023 — -$62.72M $128.04M $13.62M $114.42M
2022 — -$74.73M $184.16M $16.63M $167.53M
2021 — -$69.39M $242.39M $9.00M $233.39M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-03
Financials filed via
Form 10-K
filed 2026-03-05

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Baltimore, MD 21209
2850 QUARRY LAKE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:32 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maryland — Public Companies